165 related articles for article (PubMed ID: 8201694)
1. Flow cytometric bromodeoxyuridine/deoxyribonucleic acid bivariate analysis for predicting tumor invasiveness of upper tract urothelial cancer.
Miyakawa A; Tachibana M; Nakashima J; Deguchi N; Baba S; Tazaki H
J Urol; 1994 Jul; 152(1):76-80. PubMed ID: 8201694
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
[TBL] [Abstract][Full Text] [Related]
3. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
al-Abadi H; Nagel R
J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in patients with primary transitional cell carcinoma of the upper urinary tract.
Badalament RA; O'Toole RV; Kenworthy P; Young DC; Keyhani-Rofagha S; Simon J; Perez JF; Drago JR
J Urol; 1990 Oct; 144(4):859-63. PubMed ID: 2398559
[TBL] [Abstract][Full Text] [Related]
5. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of DNA ploidy pattern in transitional cell cancer of the renal pelvis and ureter: continuing follow-up.
Corrado F; Mannini D; Ferri C; Corrado G; Bertoni F; Bacchini P; Lieber MM; Song JM
Eur Urol; 1992; 21 Suppl 1():48-50. PubMed ID: 1425836
[TBL] [Abstract][Full Text] [Related]
7. Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis.
Corrado F; Ferri C; Mannini D; Corrado G; Bertoni F; Bacchini P; Lelli G; Lieber MM; Song JM
J Urol; 1991 Jun; 145(6):1159-63. PubMed ID: 2033684
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of primary transitional cell carcinoma of the upper urinary tract.
Lee SH; Lin JS; Tzai TS; Chow NH; Tong YC; Yang WH; Chang CC; Cheng HL
Eur Urol; 1996; 29(3):266-70; discussion 271. PubMed ID: 8740029
[TBL] [Abstract][Full Text] [Related]
9. Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma?
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S38-47. PubMed ID: 1575219
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
Miyakawa A; Tachibana M; Tazaki H
Cancer Detect Prev; 1995; 19(2):165-72. PubMed ID: 7750104
[TBL] [Abstract][Full Text] [Related]
11. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
12. Transitional cell carcinoma of the renal pelvis and ureter in Taiwan. DNA analysis by flow cytometry.
Chiang PH; Huang MS; Tsai CJ; Tsai EM; Huang CH; Chiang CP
Cancer; 1993 Jun; 71(12):3988-92. PubMed ID: 8508364
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of DNA ploidy and proliferative activity in urothelial carcinoma of the renal pelvis and ureter. A study on a follow-up period of 6 years.
Borgmann V; al-Abadi H; Nagel R
Urol Int; 1991; 47(1):7-11. PubMed ID: 1871915
[TBL] [Abstract][Full Text] [Related]
14. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Aboumohamed AA; Krane LS; Hemal AK
J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
[TBL] [Abstract][Full Text] [Related]
15. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
16. Flow DNA analysis in the characterization of carcinoma of the renal pelvis and ureter.
Oldbring J; Hellsten S; Lindholm K; Mikulowski P; Tribukait B
Cancer; 1989 Nov; 64(10):2141-5. PubMed ID: 2804903
[TBL] [Abstract][Full Text] [Related]
17. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival.
Rey A; Lara PC; Redondo E; Valdés E; Apolinario R
Cancer; 1997 Jun; 79(11):2178-85. PubMed ID: 9179065
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
[TBL] [Abstract][Full Text] [Related]
20. Quantification of cell kinetic characteristics using flow cytometric measurements of deoxyribonucleic acid and bromodeoxyuridine for bladder cancer.
Tachibana M; Deguchi N; Jitsukawa S; Baba S; Hata M; Tazaki H
J Urol; 1991 May; 145(5):963-7. PubMed ID: 2016810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
